Bioequivalence Regulations and Product-Specific Guidances

  Рет қаралды 3,065

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
Best Practices for Conducting Bioequivalence Studies (16of27) Generic Drugs Forum 2018
30:26
U.S. Food and Drug Administration
Рет қаралды 3,6 М.
Safety Reporting Requirements and Safety Assessment for IND and BA/BE Studies
35:38
U.S. Food and Drug Administration
Рет қаралды 9 М.
😜 #aminkavitaminka #aminokka #аминкавитаминка
00:14
Аминка Витаминка
Рет қаралды 2,3 МЛН
Всё пошло не по плану 😮
00:36
Miracle
Рет қаралды 5 МЛН
버블티로 부자 구별하는법4
00:11
진영민yeongmin
Рет қаралды 28 МЛН
Case Studies: Inadequate Bioequivalence Studies (18of28) Generic Drugs Forum - Apr. 3-4, 2019
23:31
Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA
1:56:59
U.S. Food and Drug Administration
Рет қаралды 10 М.
FDA Draft Guidance on Statistical Approaches to Establishing Bioequivalence
2:01:02
U.S. Food and Drug Administration
Рет қаралды 7 М.
Submitting IND Safety Reports to FDA Adverse Event Reporting System (FAERS)- Nov. 1, 2019
55:59
U.S. Food and Drug Administration
Рет қаралды 10 М.
An In-Depth Look at the Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs
2:35:24
FDA’s Bioequivalence Recommendations for Generic Drugs (16/28) Generic Drugs Forum 2017
17:35
U.S. Food and Drug Administration
Рет қаралды 2,3 М.
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 4
1:01:38
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 1
1:33:53
ICH Q12 Guidance and Emerging Technology Program (11of16) Generic Drugs Forum 2020
55:12
U.S. Food and Drug Administration
Рет қаралды 3,6 М.
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 2
1:12:08
😜 #aminkavitaminka #aminokka #аминкавитаминка
00:14
Аминка Витаминка
Рет қаралды 2,3 МЛН